Final Results from Phase II Trial of Neoadjuvant Docetaxel and Capecitabine Given Sequentially or Concurrently for HER2-Negative Breast Cancers
| Autor: | Zelnak, Amelia B., Styblo, Toncred M., Rizzo, Monica, Gabram, Sheryl G., Wood, William C., Harichand-Herdt, Seema, Kim, Sungjin, Liu, Yuan, O'Regan, Ruth M. |
|---|---|
| Zdroj: | In Clinical Breast Cancer June 2013 13(3):173-179 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect